Overall Technical outlook

Price Summary

Eris Lifesciences Limited's stock, on 2025-10-17 opened at 1571.0, climbed to a high of 1609.3, dropped to a low of 1571.0, and closed up 1.62% at 1596.4, with 80335 shares traded.
The stock reached its highest price of 1847.7 and lowest price of 1153.1 over the last 52 weeks.
10 analysts predict that the future price of ERIS will be in the range of 1680.0 to 2000.0, with a mean expected price of about 1860.1.

Technicals

Support and Resistance: The price sits at 1596.4, supported by 1512.0 and resisted by 1615.7. This indicates a trading range where 1512.0 provides a floor, preventing declines, and 1615.7 acts as a ceiling, limiting further price increases for ERIS.
ERIS supportResistance a42a11
Support/Resistance for ERIS


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
ERIS aroon a42a11
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The BOLL BANDS is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
ERIS bbands a42a11
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR has just reversed from bullish to bearish, signaling a potential trend change. If this move is confirmed by other indicators, it could indicate a strong bearish trend. Investors should be cautious and watch for further signs of a market downturn before acting.
ERIS psar a42a11
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
ERIS stoch a42a11
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages shows a bullish trend, but the declining slopes of the 20 and 50 SMAs suggest that this trend may be weakening. This loss of momentum could be a sign that the market is nearing a reversal, with the possibility of a bearish shift in price action becoming more likely in the near future.
ERIS trippleSMA a42a11
Tripple SMA chart for Eris Lifesciences Limited


To make the most of a company's technical analysis, it's important to start with an understanding of its fundamentals. These include profitability, cash flow, and competitive positioning. Additionally, the industry in which the company operates plays a critical role, as trends and external factors can influence its market performance. By considering both the company's internal fundamentals and the external industry environment, more meaningful and accurate conclusions can be drawn from the technical data.